Undisclosed program (Verve Therapeutics/Eli Lilly)

N/A

Report date: 2024/01/26 17:37:07

Base Information

Drug NameUndisclosed program (Verve Therapeutics/Eli Lilly)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsAtherosclerosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerve Therapeutics IncEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyVerve Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A